SCHEMBL12137828

SCHEMBL12137828

Cc1nc(N)nc(-c2cccc(F)c2)c1-c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 8/20 0.48
▸ ADORA1 P30542 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.46
▸ ADORA2B P29275 5/20 0.46
▸ NQO2 P16083 3/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ ATR Q13535 1/20 0.42
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CHUK O15111 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PSIP1 O75475 1/20 0.40
▸ AXL P30530 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ HPGDS O60760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12137889 0.90 KDM4E (0.44) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137832 0.88 KDM4E (0.45) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137634 0.87 AXL (0.56) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12138052 0.86 ADORA2A (0.52) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137676 0.86 ADORA2B (0.59) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137682 0.85 KDM4E (0.45) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137948 0.85 ADORA2A (0.48) ADORA2AADORA1KDM4EADORA2BCHUK
SCHEMBL12138048 0.85 CYP1A2 (0.49) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137641 0.85 NPY5R (0.55) ADORA2AADORA1KDM4EADORA2BNQO2
SCHEMBL12137885 0.84 ADORA2A (0.49) ADORA2AADORA1RXFP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 ADORA2A 314/4885ADORA1 87/4885KDM4E 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback